APA (7th ed.) Citation

MH, D., ZC, M., LQ, Z., M, H., LL, X., YX, L., . . . DS, T. (2025). Anti-BCMA CAR-T cell therapy in relapsed/refractory chronic inflammatory demyelinating polyneuropathy. Med (New York, N.Y.), 6(9), 100704. https://doi.org/10.1016/j.medj.2025.100704

Chicago Style (17th ed.) Citation

MH, Dong, et al. "Anti-BCMA CAR-T Cell Therapy in Relapsed/refractory Chronic Inflammatory Demyelinating Polyneuropathy." Med (New York, N.Y.) 6, no. 9 (2025): 100704. https://doi.org/10.1016/j.medj.2025.100704.

MLA (9th ed.) Citation

MH, Dong, et al. "Anti-BCMA CAR-T Cell Therapy in Relapsed/refractory Chronic Inflammatory Demyelinating Polyneuropathy." Med (New York, N.Y.), vol. 6, no. 9, 2025, p. 100704, https://doi.org/10.1016/j.medj.2025.100704.